These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Sun J; Wang S; Zhao D; Hun FH; Weng L; Liu H Cell Biol Toxicol; 2011 Oct; 27(5):333-42. PubMed ID: 21681618 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. Li Y; Zhang W; Niu J; Chen Y ACS Nano; 2012 Jun; 6(6):5164-73. PubMed ID: 22587225 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Pan X; Redding JE; Wiley PA; Wen L; McConnell JS; Zhang B Chemosphere; 2010 Mar; 79(1):113-6. PubMed ID: 20106502 [TBL] [Abstract][Full Text] [Related]
8. Toxicity of nanoparticulate and bulk ZnO, Al2O3 and TiO2 to the nematode Caenorhabditis elegans. Wang H; Wick RL; Xing B Environ Pollut; 2009 Apr; 157(4):1171-7. PubMed ID: 19081167 [TBL] [Abstract][Full Text] [Related]
9. Toxicological effect of ZnO nanoparticles based on bacteria. Huang Z; Zheng X; Yan D; Yin G; Liao X; Kang Y; Yao Y; Huang D; Hao B Langmuir; 2008 Apr; 24(8):4140-4. PubMed ID: 18341364 [TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Kumar A; Pandey AK; Singh SS; Shanker R; Dhawan A Chemosphere; 2011 May; 83(8):1124-32. PubMed ID: 21310462 [TBL] [Abstract][Full Text] [Related]
11. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014 [TBL] [Abstract][Full Text] [Related]
12. Adsorption of hematite nanoparticles onto Caco-2 cells and the cellular impairments: effect of particle size. Zhang W; Kalive M; Capco DG; Chen Y Nanotechnology; 2010 Sep; 21(35):355103. PubMed ID: 20693617 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. Liu Y; He L; Mustapha A; Li H; Hu ZQ; Lin M J Appl Microbiol; 2009 Oct; 107(4):1193-201. PubMed ID: 19486396 [TBL] [Abstract][Full Text] [Related]
16. Bacteria and bacteriophage inactivation by silver and zinc oxide nanoparticles. You J; Zhang Y; Hu Z Colloids Surf B Biointerfaces; 2011 Jul; 85(2):161-7. PubMed ID: 21398101 [TBL] [Abstract][Full Text] [Related]
17. Surface interactions affect the toxicity of engineered metal oxide nanoparticles toward Paramecium. Li K; Chen Y; Zhang W; Pu Z; Jiang L; Chen Y Chem Res Toxicol; 2012 Aug; 25(8):1675-81. PubMed ID: 22693953 [TBL] [Abstract][Full Text] [Related]
18. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Gogoi SK; Gopinath P; Paul A; Ramesh A; Ghosh SS; Chattopadhyay A Langmuir; 2006 Oct; 22(22):9322-8. PubMed ID: 17042548 [TBL] [Abstract][Full Text] [Related]
19. Responses of a soil bacterium, Pseudomonas chlororaphis O6 to commercial metal oxide nanoparticles compared with responses to metal ions. Dimkpa CO; Calder A; Britt DW; McLean JE; Anderson AJ Environ Pollut; 2011 Jul; 159(7):1749-56. PubMed ID: 21550151 [TBL] [Abstract][Full Text] [Related]
20. Bacterial toxicity comparison between nano- and micro-scaled oxide particles. Jiang W; Mashayekhi H; Xing B Environ Pollut; 2009 May; 157(5):1619-25. PubMed ID: 19185963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]